Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies

Overview of attention for article published in Journal of Pain Research, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 1 news story.

Subcutaneous methylnaltrexone may reduce rescue-free laxation time in patients with advanced illness and opioid induced…